Home
>
National Drug Code (NDC)
>
OXY Clinical
OXY Clinical - 10742-8214-1 - (Salicylic acid)
Drug Information of OXY Clinical
| Product NDC: | 10742-8214 |
| Proprietary Name: | OXY Clinical |
| Non Proprietary Name: | Salicylic acid |
| Active Ingredient(s): | 20 mg/mL & nbsp; Salicylic acid |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of OXY Clinical
| Product NDC: | 10742-8214 |
| Labeler Name: | The Mentholatum Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100601 |
Package Information of OXY Clinical
| Package NDC: | 10742-8214-1 |
| Package Description: | 150 mL in 1 BOTTLE (10742-8214-1) |
NDC Information of OXY Clinical
| NDC Code | 10742-8214-1 |
| Proprietary Name | OXY Clinical |
| Package Description | 150 mL in 1 BOTTLE (10742-8214-1) |
| Product NDC | 10742-8214 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Salicylic acid |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20100601 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | The Mentholatum Company |
| Substance Name | SALICYLIC ACID |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
